Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of Bath Wipes After Hematopoietic Cell Transplantation: A Randomized Trial.
Kjellin M, Qudeimat A, Browne E, Keerthi D, Sunkara A, Kang G, Winfield A, Giannini MA, Maron G, Hayden R, Leung W, Triplett B, Srinivasan A. Kjellin M, et al. Among authors: qudeimat a. J Pediatr Oncol Nurs. 2020 Nov/Dec;37(6):390-397. doi: 10.1177/1043454220944061. Epub 2020 Jul 24. J Pediatr Oncol Nurs. 2020. PMID: 32706285 Free PMC article. Clinical Trial.
Case Report: Management Approach and Use of Extracorporeal Membrane Oxygenation for Diffuse Alveolar Hemorrhage After Pediatric Hematopoietic Cell Transplant.
Fan K, Hurley C, McNeil MJ, Agulnik A, Federico S, Qudeimat A, Saini A, McArthur J, Morrison RR, Sandhu H, Shah S, Ghafoor S. Fan K, et al. Among authors: qudeimat a. Front Pediatr. 2021 Jan 13;8:587601. doi: 10.3389/fped.2020.587601. eCollection 2020. Front Pediatr. 2021. PMID: 33520888 Free PMC article.
Outcomes following intolerance to calcineurin inhibitor-based graft-versus-host disease prophylaxis in children after allogeneic hematopoietic cell transplantation.
Wu D, Li Y, Bi Y, Lannom TM, Ward DA, Qudeimat A, Madden RM, Sharma A, Epperly R, Mamcarz E, Talleur A, Naik S, Selukar S, Triplett B, Srinivasan A. Wu D, et al. Among authors: qudeimat a. Pediatr Blood Cancer. 2023 Jun 20:e30517. doi: 10.1002/pbc.30517. Online ahead of print. Pediatr Blood Cancer. 2023. PMID: 37338275
Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution.
Mamcarz E, Madden R, Qudeimat A, Srinivasan A, Talleur A, Sharma A, Suliman A, Maron G, Sunkara A, Kang G, Leung W, Gottschalk S, Triplett BM. Mamcarz E, et al. Among authors: qudeimat a. Bone Marrow Transplant. 2020 May;55(5):929-938. doi: 10.1038/s41409-019-0750-7. Epub 2019 Nov 18. Bone Marrow Transplant. 2020. PMID: 31740766 Free PMC article.
Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML.
Pfeiffer T, Li Y, Ashcraft E, Karol SE, Rubnitz JE, Epperly R, Madden R, Mamcarz E, Obeng E, Qudeimat A, Sharma A, Srinivasan A, Suliman A, Talleur AC, Velasquez MP, Gottschalk S, Triplett BM, Naik S. Pfeiffer T, et al. Among authors: qudeimat a. Bone Marrow Transplant. 2023 Mar;58(3):328-331. doi: 10.1038/s41409-022-01877-2. Epub 2022 Nov 29. Bone Marrow Transplant. 2023. PMID: 36443431 No abstract available.
Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients.
Epperly R, Talleur AC, Li Y, Schell S, Tuggle M, Métais JY, Huang S, Pei D, Cheng C, Madden R, Mamcarz E, Naik S, Qudeimat A, Sharma A, Srinivasan A, Suliman A, Gottschalk S, Triplett BM. Epperly R, et al. Among authors: qudeimat a. Transplant Cell Ther. 2022 May;28(5):262.e1-262.e10. doi: 10.1016/j.jtct.2022.02.007. Epub 2022 Feb 11. Transplant Cell Ther. 2022. PMID: 35151936 Free PMC article. Clinical Trial.
Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS.
Sharma A, Li Y, Huang S, Talleur AC, Suliman A, Qudeimat A, Srinivasan A, Mamcarz E, Madden R, Cheng C, Gottschalk S, Triplett BM. Sharma A, et al. Among authors: qudeimat a. Bone Marrow Transplant. 2021 Aug;56(8):1866-1875. doi: 10.1038/s41409-021-01267-0. Epub 2021 Mar 19. Bone Marrow Transplant. 2021. PMID: 33742153
Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.
Talleur AC, Qudeimat A, Métais JY, Langfitt D, Mamcarz E, Crawford JC, Huang S, Cheng C, Hurley C, Madden R, Sharma A, Suliman A, Srinivasan A, Velasquez MP, Obeng EA, Willis C, Akel S, Karol SE, Inaba H, Bragg A, Zheng W, Zhou SM, Schell S, Tuggle-Brown M, Cullins D, Patil SL, Li Y, Thomas PG, Zebley C, Youngblood B, Pui CH, Lockey T, Geiger TL, Meagher MM, Triplett BM, Gottschalk S. Talleur AC, et al. Among authors: qudeimat a. Blood Adv. 2022 Nov 8;6(21):5737-5749. doi: 10.1182/bloodadvances.2021006293. Blood Adv. 2022. PMID: 35446934 Free PMC article. Clinical Trial.
14 results